A phase I/II trial of ZIO-101 [darinaparsin] in advanced multiple myeloma.
Phase of Trial: Phase I/II
Latest Information Update: 10 Oct 2013
At a glance
- Drugs Darinaparsin (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 18 Jul 2012 Actual end date (Aug 2007) added as reported by ClinicalTrials.gov.
- 07 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Dec 2007 Status changed from recruiting to in progress.